Drug
Poloxamer clinical trials
Also written MST-188.
- studies test it
- 9
- open now
- 0
- in phase 3
- 3
- first study started
- 1997
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
9 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
- Phase 3
- 3
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 2
Mast Therapeutics, Inc. (7) · University of Virginia (2)
Often tested with
Tested in the same studies.
Povidone-Iodine (2) · Chlorhexidine (2) · Chlorhexidine gluconate (1)
Studies
Open first, then newest update. How each study uses Poloxamer is read from its arms, and is right about nine times in ten.
Testing it · 9
- Topical Umbilical Cord Care for the Prevention of Colonization and Invasive InfectionsCompletedNot applicableUniversity of VirginiaNCT01886001Written as Pluronic
- Study of the Effect of Renal Impairment on the Pharmacokinetics of VepoloxamerCompletedPhase 1Mast Therapeutics, Inc.NCT02646358Written as Vepoloxamer
- Evaluation of Repeat Administration of Purified Poloxamer 188CompletedPhase 3Mast Therapeutics, Inc.NCT02449616Written as MST-188
- Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)CompletedPhase 3Mast Therapeutics, Inc.NCT01737814Written as MST-188
- Evaluation of Vepoloxamer in Chronic Heart FailureTerminatedPhase 2Mast Therapeutics, Inc.NCT02596477Written as Vepoloxamer
- Evaluation of MST-188 in Acute Lower Limb IschemiaTerminatedPhase 2Mast Therapeutics, Inc.NCT02093468Written as MST-188
- ANX-188 Thorough QT/QTc Study in Healthy VolunteersCompletedPhase 1Mast Therapeutics, Inc.NCT01790087Written as ANX-188 Therapeutic Dose
- Umbilical Cord Care for the Prevention of ColonizationStatus unknownNot applicableUniversity of VirginiaNCT01893060Written as Pluronic Cream
- Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell DiseaseCompletedPhase 3Mast Therapeutics, Inc.NCT00004408Written as poloxamer 188
Codes
What other systems call Poloxamer · ClinicalTrials.gg INT008763
Also registered as poloxamer 188 (UNII LQA7B6G8JG · RxNorm 155152) and poloxamer 407 (UNII TUF2IVW3M2 · RxNorm 155155).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.